Aprea TherapeuticsAPRE
13F holders, Q3 2024 (September 30)1holders
0new positions
0sold out
$2.22avg. 13F price*
At the end of Q3 2024, 1 institutions reported holding Aprea Therapeutics Inc. (APRE) in their 13F filings, unchanged from Q2 2024. 0 opened new positions and 0 sold out. The largest holder was Lanark Financial, Inc. ($2K).
- Company
- Aprea Therapeutics Inc.
- CUSIP
- 03836J102
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Lanark Financial, Inc. | 0.00% | No change | 899 | $2K |
"% of holder's portfolio" is APRE's weight in each manager's 13F, not the share of Aprea Therapeutics Inc. the manager owns.